1. P1–019: Systemic administration of insulin‐like growth factor 2 results in increased BOLD pharmacological MRI response in memory‐related brain regions. (1st July 2013) Authors: Lea Shamy, Jul; Kulkarni, Praveen; Meadowcroft, Mark; Nedelman, Mark; Alberini, Cristina; Ferris, Craig; Baxter, Mark Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 4 Page Start: P159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P4‐015: The 5‐HT6 Receptor Antagonist Idalopirdine (LU AE58054) and Acetylcholinesterase Inhibitor Donepezil have Synergistic Effects on Brain Activity: A Pharmacological MRI Study in the Awake Rat. (1st July 2016) Authors: de Jong, Inge E.M.; Pedersen, Jan T.; Kulkarni, Praveen; Nedelman, Mark; Ferris, Craig Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 21 Page Start: P1020 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets. Issue 2 (28th June 2019) Authors: Vootukuri, Spandana; Li, Jihong; Nedelman, Mark; Thomas, Craig; Jiang, Jiang-Kang; Babayeva, Mariana; Coller, Barry S. Journal: Journal of clinical and translational science Issue: Volume 3:Issue 2/3(2019) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗